Translate Bio
is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of genetic diseases... Read moreTranslate Bio
is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of genetic diseases... Read more
CEO
Add
News
Sep 27, 2021
LaingBuisson
Translate Bio: France: Sanofi completes acquisition of Translate Bio
Sep 15, 2021
PharmiWeb
Translate Bio: Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics
Sep 13, 2021
Seeking Alpha
Translate Bio: Merger Arbitrage Mondays - Sanofi's Second Purchase In 6 Weeks
Sep 08, 2021
BioSpace
Translate Bio: Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Sep 08, 2021
Aug 06, 2021
MarketScreener
Translate Bio: Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Aug 04, 2021
Contract Pharma
Translate Bio: Sanofi to Acquire Translate Bio for $3.2B
Aug 04, 2021
Zacks
Translate Bio: Sanofi to Buy mRNA Developer: ETFs in Focus
Aug 03, 2021
Entrepreneur
Translate Bio: Hot Biotech Stocks To Watch After Sanofi's Acquisition Of Translate Bio
Aug 03, 2021
FinSMEs
Translate Bio: Sanofi to Buy Translate Bio, For $3.2 Billion
Aug 03, 2021
International Business Times
Translate Bio: France's Sanofi Expands MRNA Drive With US Firm Purchase
Translate Bio Competitors
1
2
3
4
5
6
7
8
9
10